Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEYOND trial of Rekovelle in long GnRH agonist versus GnRH antagonist protocols for IVF/ICSI
MOH_2019-08-26_007365Phase 2Not yet recruiting
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of recombinant human follicle stimulating hormone in female infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Number of oocytes retrieved. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
female infertility
Beyond the preview
Go deeper on MOH_2019-08-26_007365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-08-26_007365.